Position in REGN
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$597,351
-$63,256 QoQ
Shares Held
958
+12.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#205
of 454 holders
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026J.W. COLE ADVISORS, INC. holds $3,075,638 across 11 Biotechnology names. REGN ranks #2 (19.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,414 | $702,376 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
958 | $597,351 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
2,722 | $509,776 | |
| 4 | ACAD |
Acadia Pharmaceuticals Inc
|
16,906 | $427,721 | |
| 5 | EXEL |
Exelixis, Inc.
|
5,934 | $322,868 | |
| 6 | INCY |
Incyte Corp
|
2,210 | $250,525 | |
| 7 | VCEL |
Vericel Corp
|
4,700 | $209,103 | |
| 8 | CRBU |
Caribou Biosciences, Inc.
|
11,269 | $19,833 |
All Filings in REGN
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $597,351 | 958 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $660,607 | 855 | Shares | Sole | 2026-04-23 | |
| 2025-09-30 | $512,227 | 911 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $523,425 | 997 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $610,763 | 963 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $446,630 | 627 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $843,094 | 802 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $755,690 | 719 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $726,679 | 755 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $690,335 | 786 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $641,908 | 780 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $633,033 | 881 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $774,834 | 943 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $509,371 | 706 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $495,297 | 719 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $460,490 | 779 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $588,069 | 842 | Shares | Sole | 2022-06-10 | |
| 2021-12-31 | $539,318 | 854 | Shares | Sole | 2022-01-25 | |
| 2021-09-30 | $540,425 | 893 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $499,893 | 895 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $207,235 | 438 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $258,946 | 536 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $274,292 | 490 | Shares | Sole | 2020-11-05 | |
| No filing history on record for this holder in this stock. | ||||||